|
Real-time Estimate
Cboe BZX
01:29:57 24/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 1.565 USD | -6.29% |
|
-2.34% | -81.51% |
| 15/10 | EnGene Therapeutics Inc. - Special Call | |
| 21/09 | EnGene Therapeutics Inc.(NasdaqCM:ENGN) dropped from S&P Global BMI Index | CI |
| Market Cap | 11Cr 9.46Cr 8.74Cr 7.92Cr 15Cr 1.01TCr 15Cr 105.12Cr 42Cr 526.64Cr 40Cr 39Cr 1.66TCr | P/E 2026 * |
-0.86x | P/E 2027 * | -1.04x |
|---|---|---|---|---|---|
| Enterprise Value | -7.86Cr -7.02Cr -6.49Cr -5.88Cr -11Cr -746.5Cr -11Cr -78Cr -31Cr -391.12Cr -30Cr -29Cr -1.23TCr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 5.61x |
| Free-Float |
99.89% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ENGN | End-of-day quote | |
CBOE
| ENGN | Real-time | |
|
Deutsche Boerse AG
| S0N0 | Delayed |
Last Transcript: enGene Therapeutics Inc.
| 1 day | +5.70% | ||
| 1 week | -2.34% | ||
| Current month | -16.50% | ||
| 1 month | -18.54% | ||
| 3 months | -9.73% | ||
| 6 months | -80.44% | ||
| Current year | -81.51% |
| 1 week | 1.54 |  | 1.72 |
| 1 month | 1.54 | | 2.02 |
| Current year | 1.4 | | 12.25 |
| 1 year | 1.4 | | 12.25 |
| 3 years | 1.4 | | 47.17 |
| 5 years | 1.4 | | 47.17 |
| 10 years | 1.4 | | 47.17 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ronald Cooper
CEO | Chief Executive Officer | 63 | 22/07/2024 |
Kathleen Richton
DFI | Director of Finance/CFO | 48 | 16/07/2026 |
William Grossman
CTO | Chief Tech/Sci/R&D Officer | 56 | 15/06/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Gerry Brunk
BRD | Director/Board Member | 57 | 08/08/2023 |
Lota Zoth
BRD | Director/Board Member | 66 | 18/12/2023 |
Paul Hastings
BRD | Director/Board Member | 66 | 15/05/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 22/09/26 | Buy | Chief Technology Officer | 5,102 | 0.0076% | ||
| 16/07/26 | Other | Interim Chief Business Officer | 75,000 | 0.1120% | ||
| 16/07/26 | Other | Chief Financial Officer | 0 | 0% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.29% | -2.34% | -79.38% | -83.30% | 11Cr | |
| +2.41% | -6.33% | +43.43% | +71.02% | 6.33TCr | |
| -0.15% | +3.11% | +10.29% | +72.56% | 5.49TCr | |
| +0.57% | +4.64% | +12.82% | +89.79% | 5.33TCr | |
| +0.37% | +3.07% | +28.23% | +51.53% | 4.58TCr | |
| -1.21% | +0.95% | +20.44% | +128.58% | 4.35TCr | |
| -0.37% | -1.20% | +252.94% | +568.54% | 4.02TCr | |
| +0.05% | +6.75% | +14.48% | +56.75% | 3.35TCr | |
| +1.19% | -5.84% | +27.86% | -0.65% | 2.37TCr | |
| -0.38% | +4.55% | +37.71% | +28.10% | 2.38TCr | |
| Average | +0.82% | +1.00% | +36.88% | +98.29% | 3.82TCr | |
| Weighted average by Cap. | +0.38% | +0.56% | +48.13% | +122.06% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 55.97L 49.98L 46.17L 41.84L 78.28L 53Cr 79.57L 5.56Cr 2.2Cr 28Cr 2.1Cr 2.06Cr 88Cr |
| Net income | -12Cr -11Cr -10Cr -9.31Cr -17Cr -1.18TCr -18Cr -123.58Cr -49Cr -619.13Cr -47Cr -46Cr -1.95TCr | -11Cr -10Cr -9.28Cr -8.41Cr -16Cr -1.07TCr -16Cr -111.68Cr -44Cr -559.54Cr -42Cr -41Cr -1.76TCr |
| Net Debt | -18Cr -16Cr -15Cr -14Cr -26Cr -1.75TCr -26Cr -183.18Cr -73Cr -917.76Cr -69Cr -68Cr -2.89TCr | -7.45Cr -6.65Cr -6.14Cr -5.57Cr -10Cr -706.87Cr -11Cr -74Cr -29Cr -370.36Cr -28Cr -27Cr -1.17TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/26/20 | $1.670 | +5.70% | 11,19,792 |
| 23/26/23 | $1.560 | -1.27% | 7,30,197 |
| 22/26/22 | $1.580 | -3.07% | 5,54,578 |
| 21/26/21 | $1.630 | -2.40% | 11,08,892 |
| 20/26/20 | $1.670 | +5.70% | 11,19,792 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ENGN Stock
Select your edition
All financial news and data tailored to specific country editions
